Clinical trial

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to…

NCT00035542 · Bristol-Myers Squibb, Industry · Completed

Key facts

NCT number NCT00035542
Title A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
Lead sponsor Bristol-Myers Squibb, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Diabetes Mellitus, Non-Insulin-Dependent
Intervention type Drug
Interventions Glucovance (metformin HCl/glyburide), metformin HCl, glyburide
Start date Dec 1, 2001
Primary completion Oct 1, 2003
Completion Oct 1, 2003
First posted May 6, 2002
Last update posted Apr 15, 2011
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies